The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
https://twitter.com/JamesBenamor/status/1267459828886261764/photo/2
Hope the link works.
Who do we think instigated the FCA enquiry?
The founder, who has made his opinions clear on twitter.
The third party bidder, having seen the books.
The board, to cover themselves.
The FCA ,as its all in the public domain.
Take your pick.
Means FDA.
Not passed phase III.
Plus the shares added tomorrow as in this mornings RNS.
Completion of Conditional Placing of £146,250 gross
The approval of the resolutions enables the Conditional Placing, announced on 30 March, to be completed. As a result, 182,812,500 ordinary shares have been issued and will be admitted to trading on AIM on 1 May 2020.
MTFB is a cash shell i.e. no assets only cash
An RTO wont give anybody access to iclaprim.
Right to Iclaprim given to lender Hercules,
Six ex directors have options at 2.4 pence.
Hurcules have warrants at 4.2p.
Where has the SP just been .
Digger88
Oli Search $3.10 see below
https://www.oilsearch.com/__data/assets/pdf_file/0005/13676/171101-Strategic-acquisition-of-interests-in-the-Alaska-North-Slope.pdf
Have they run out of money to pay him.
Update on drilling operations in Morocco and Egypt
Morocco
SDX Energy Plc (AIM: SDX), the MENA-focused oil and gas company, is pleased to announce that the OYF-2 well in Morocco (SDX 75% working interest) has been drilled to a measured depth of 1,210 meters and has encountered commercial quantities of gas in excess of pre-drill estimates. The discovery also confirms that the Company's core productive area extends to the north.
Both the Upper and Lower Guebbas targets in OYF-2 were encountered and reservoir thickness and quality were better than pre-drill expectations. The Upper Guebbas was encountered at a measured depth of 1,001 meters, while the Lower Guebbas was penetrated at a measured depth of 1,120 meters.
Management estimates that approximately 1.3 to 1.9 bcf1 of gas is recoverable from the horizons encountered by the OYF-2 well, which will be tested in February. The discovery will be tied into the Company's infrastructure when required, at an estimated cost of approximately US$2 million net to SDX. Furthermore, the discovery has de-risked a further 0.5 to 1.0 bcf of Prospective Resources2 in the western compartment of the Lower Guebbas target which the Company expects to recover with a single development well in the future.
The rig has now moved to the BMK-1 location, which is approximately 11 kilometres to the north of OYF-2. BMK-1 will again test the extent of the northern expansion of the Company's core productive area and, if successful, could de-risk a number of similar close-by prospects. After BMK-1, one more close to infrastructure well and two other potentially play-opening wells in Lalla Mimouna will be drilled to complete the campaign in March.
SDX Energy
Delayed from yesterday but SDX in a detailed statement updated the market on production, capex and added some guidance for this year. 2019 production was 4,020 boe/d, up 12% and at the upper end of guidance. 2020 guidance is 6,750-7000 boe/d obviously not like for like particularly after the delayed South Disouq came onstream and also includes 1,000-1,050 from NW Gemsa which is potentially for sale.
2019 capex was $40.7m, $4.5m higher due to two extra wells in Morocco whilst for 2020 the number falls to $25.5m as the 12 well program in Morocco completes but with 2 in Egypt and up to 3 appraisal/development wells in the West Gharb concession. The company is fully funded from cash internally generated from operations, in the balance sheet and the EBRD facility which could be increased. Finally the company has warned about non-cash impairments of some $18m at the final stage.
The 16% has come from HotCopper, quoting an Australian article.
I don't know how they have arrived at that figure, as no official figures have been announced.
The discount in previous placings have been 20%,
Double Blind Trial wasn't it, protocol agreed with the FDA.
Whats the real reason that you hate Lumsden?
Your jobs done, now you can tell us.
I'm surprised they have held this long, to be honest!